Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Phase 1b/2 study evaluating safety, efficacy and immune effects of TLR9 agonist cavrotolimod with anti-PD-1 antibodies among patients with advanced solid tumors.
Journal: Journal for immunotherapy of cancer
Published: July 04, 2025
The telomerase vaccine UV1 combined with ipilimumab and nivolumab versus ipilimumab and nivolumab in advanced melanoma (INITIUM): A randomized open-label phase 2 study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 27, 2025
Cancer Immunotherapy Trials Network 12: Pembrolizumab in HIV-Associated Kaposi Sarcoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 02, 2024
Clinical benefit with tebentafusp in a patient with GNAQ mutant metastatic blue nevus-associated melanoma.
Journal: Journal for immunotherapy of cancer
Published: September 23, 2024
Diagnosis and management of bispecific T cell-engaging antibody toxicity: A primer for emergency physicians.
Journal: Cancer treatment reviews
Published: September 11, 2024
PGV001, a Multi-Peptide Personalized Neoantigen Vaccine Platform: Phase I Study in Patients with Solid and Hematologic Malignancies in the Adjuvant Setting.
Journal: Cancer discovery
Published: June 28, 2024
Metastatic merkel cell carcinoma to the thyroid gland: Case report and review of the literature.
Journal: American journal of otolaryngology
Published: January 24, 2024
Case report: Regression of in-transit metastases of cutaneous squamous cell carcinoma with combination pembrolizumab and topical diphencyprone.
Journal: Frontiers in oncology
Published: September 14, 2023
Talimogene laherparepvec in combination with ipilimumab versus ipilimumab alone for advanced melanoma: 5-year final analysis of a multicenter, randomized, open-label, phase II trial.
Journal: Journal for immunotherapy of cancer
Published: March 31, 2023
Preclinical Activity of 4-Demethyl-4-cholesteryloxycarbonylpenclomedine in Melanoma.
Journal: Anticancer research
Published: January 03, 2023
A phase 1 study of NY-ESO-1 vaccine + anti-CTLA4 antibody Ipilimumab (IPI) in patients with unresectable or metastatic melanoma.
Journal: Oncoimmunology
Published: April 02, 2021
Last Updated: 09/26/2026